Cormorant Asset Management, LP Protara Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.43 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$8.68 - $16.99 $3.04 Million - $5.95 Million
-350,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$16.97 - $25.34 $1.7 Million - $2.53 Million
-100,000 Reduced 22.22%
350,000 $8.47 Million
Q3 2020

Nov 16, 2020
BUY
$16.76 - $31.89 $7.54 Million - $14.4 Million
450,000 New
450,000 $7.57 Million

Others Institutions Holding TARA

# of Institutions
39
Shares Held
10.7M
Call Options Held
9K
Put Options Held
1.8K
View Full List

About Protara Therapeutics, Inc.

TARA Quotes by TradingView
  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $62.1M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email